DAPK1 and cancer: In a large cohort of 507 ovarian tissues, comparing DAPK1 expression in benign and malignant epithelial ovarian tissues revealed a significant downregulation of DAPK1 in cancer tissues by a factor of 6.1 (Figure 2A).